We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.

Scientific Presentations & Posters

2019
  • Alpha-synuclein-PET imaging agent

    Identification and characterization of selective and high affinity small molecules for positron emission tomography (PET) imaging of pathological alpha-synuclein 
    Date: March 29, 2019 | 8.45 - 9.00 am WET 
    Location: Auditorium III+IV
    Presenter: Oral presentation by F. Capotosti

    Download the PDF

  • Tau-PET imaging agent

    Determination of the optimal scanning time for the assessment of Tau deposition in Alzheimer's disease using PI-2620 PET
    Date: March 29, 2019 | 8.30 - 8.45 am WET
    Location: Auditorium III+IV
    Presenter: Oral presentation by A. Stephens

    Download the PDF

  • Tau-PET imaging agent

    18F-PI-2620 Tau-PET in progressive supranuclear palsy - a multi-center evaluation

    Date: March 31 2019 | 14.00 - 14.15 pm WET
    Location: Auditorium VI+VII
    Presenter: Oral presentation by T. Van Eimeren

    Download the PDF

  • Tau-PET imaging agent

    Evaluation of Tau deposition in amyloid positive MCI or mild-AD dementia subjects from the elenbecestat MissionAD program using 18F-PI-2620 PET

    Date: March 27-28 | 6.00 - 16.00 pm WET
    Location: Exhibition
    Presenter: Poster presentation by A. Stephens

    Download the PDF

  • Compounds targeting Tau aggregation

    Small molecules targeting Tau propagation demonstrate efficacy in an aggressive tauopathy mouse model
    Date: March 31, 2019 | 11.00 - 11.15 am WET
    Location: Auditorium II
    Presenter: Oral presentation by S. Poli

    Download the PDF

  • Anti-TDP-43 antibodies

    Discovery and development of diagnostics and therapeutics for TDP-43 proteinopathies
    Date: March 31, 2019 | 11.45 am - 12.00 pm WET
    Location: Auditorium II
    Presenter: Oral presentation by T. Seredenina

    Download the PDF


2018
  • Alpha-synuclein-PET imaging agent

    Identification and characterization of selective and high affinity small molecules for positron emission tomography (PET) imaging of pathological alpha-synuclein 
    Date: March 29, 2019 | 8.45 - 9.00 am WET 
    Location: Auditorium III+IV
    Presenter: Oral presentation by F. Capotosti

    Download the PDF

  • Tau-PET imaging agent

    Determination of the optimal scanning time for the assessment of Tau deposition in Alzheimer's disease using PI-2620 PET
    Date: March 29, 2019 | 8.30 - 8.45 am WET
    Location: Auditorium III+IV
    Presenter: Oral presentation by A. Stephens

    Download the PDF

  • Tau-PET imaging agent

    18F-PI-2620 Tau-PET in progressive supranuclear palsy - a multi-center evaluation

    Date: March 31 2019 | 14.00 - 14.15 pm WET
    Location: Auditorium VI+VII
    Presenter: Oral presentation by T. Van Eimeren

    Download the PDF

  • Tau-PET imaging agent

    Evaluation of Tau deposition in amyloid positive MCI or mild-AD dementia subjects from the elenbecestat MissionAD program using 18F-PI-2620 PET

    Date: March 27-28 | 6.00 - 16.00 pm WET
    Location: Exhibition
    Presenter: Poster presentation by A. Stephens

    Download the PDF

  • Compounds targeting Tau aggregation

    Small molecules targeting Tau propagation demonstrate efficacy in an aggressive tauopathy mouse model
    Date: March 31, 2019 | 11.00 - 11.15 am WET
    Location: Auditorium II
    Presenter: Oral presentation by S. Poli

    Download the PDF

  • Anti-TDP-43 antibodies

    Discovery and development of diagnostics and therapeutics for TDP-43 proteinopathies
    Date: March 31, 2019 | 11.45 am - 12.00 pm WET
    Location: Auditorium II
    Presenter: Oral presentation by T. Seredenina

    Download the PDF


2017
  • Alpha-synuclein-PET imaging agent

    Identification and characterization of selective and high affinity small molecules for positron emission tomography (PET) imaging of pathological alpha-synuclein 
    Date: March 29, 2019 | 8.45 - 9.00 am WET 
    Location: Auditorium III+IV
    Presenter: Oral presentation by F. Capotosti

    Download the PDF

  • Tau-PET imaging agent

    Determination of the optimal scanning time for the assessment of Tau deposition in Alzheimer's disease using PI-2620 PET
    Date: March 29, 2019 | 8.30 - 8.45 am WET
    Location: Auditorium III+IV
    Presenter: Oral presentation by A. Stephens

    Download the PDF

  • Tau-PET imaging agent

    18F-PI-2620 Tau-PET in progressive supranuclear palsy - a multi-center evaluation

    Date: March 31 2019 | 14.00 - 14.15 pm WET
    Location: Auditorium VI+VII
    Presenter: Oral presentation by T. Van Eimeren

    Download the PDF

  • Tau-PET imaging agent

    Evaluation of Tau deposition in amyloid positive MCI or mild-AD dementia subjects from the elenbecestat MissionAD program using 18F-PI-2620 PET

    Date: March 27-28 | 6.00 - 16.00 pm WET
    Location: Exhibition
    Presenter: Poster presentation by A. Stephens

    Download the PDF

  • Compounds targeting Tau aggregation

    Small molecules targeting Tau propagation demonstrate efficacy in an aggressive tauopathy mouse model
    Date: March 31, 2019 | 11.00 - 11.15 am WET
    Location: Auditorium II
    Presenter: Oral presentation by S. Poli

    Download the PDF

  • Anti-TDP-43 antibodies

    Discovery and development of diagnostics and therapeutics for TDP-43 proteinopathies
    Date: March 31, 2019 | 11.45 am - 12.00 pm WET
    Location: Auditorium II
    Presenter: Oral presentation by T. Seredenina

    Download the PDF